Edwards Lifesciences Corp (EW)
Debt-to-equity ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 9,998,400 | 9,545,600 | 7,437,400 | 7,117,900 | 6,650,000 | 6,657,500 | 6,375,700 | 5,978,000 | 5,806,700 | 6,217,800 | 5,943,600 | 5,844,900 | 5,835,900 | 5,541,300 | 5,133,300 | 4,658,400 | 4,574,300 | 4,210,300 | 3,839,100 | 3,901,100 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $9,998,400K
= 0.00
The debt-to-equity ratio for Edwards Lifesciences Corp has consistently been 0.00 for the past several quarters, including the period from March 31, 2020, to December 31, 2024. This indicates that the company has been financing its operations primarily through equity rather than debt during this time frame. A debt-to-equity ratio of 0.00 suggests that the company has either minimal or no debt relative to its equity, which can be seen as a positive indicator of financial health and stability. It shows that Edwards Lifesciences Corp has a strong equity base and is not heavily reliant on borrowing to fund its operations and growth. While a low debt-to-equity ratio can be favorable in terms of financial risk, it's also essential to consider other financial metrics and factors to get a holistic view of the company's financial performance and stability.
Peer comparison
Dec 31, 2024